Drug Topics

JUNE 5, 2023

Patients were more likely to require ICU admission.

Hospitals 469

Hospitals 469

Drug Topics

NOVEMBER 16, 2023

VAERS was designed to collect reports of symptoms, diagnoses, hospital admissions, and deaths after vaccination for postmarket safety signals.

Vaccines 469

Vaccines Hospitals 469

Drug Topics

DECEMBER 10, 2024

Medication alerts, nurse education, and pharmacist interventions led to lower hypoglycemic events every year after they were implemented.

247

247

Drug Topics

SEPTEMBER 6, 2022

Patients who received the chemotherapies paclitaxel and docetaxel were at an increased risk of adverse events of the eye.

Chemotherapy 247

Chemotherapy 247

Drug Topics

SEPTEMBER 18, 2023

From automated medication dispensing systems to telepharmacy services, technology can help reduce the risk of adverse patient events.

Medication Dispensing 618

Medication Dispensing 618

Drug Topics

OCTOBER 2, 2024

In posters presented at the Heart Failure Society of America 2024 Annual Meeting, researchers assessed how substance use disorders impact cardiovascular outcomes.

281

281

Drug Topics

JULY 22, 2024

The most common adverse events in patients using oral corticosteroids for more than 90 days included fracture, hyperlipidemia, myocardial infarction, and avascular necrosis.

216

216

Drug Topics

FEBRUARY 20, 2024

Drug Topics sat down with Jude Dieterman, CEO of Outcomes, to discuss the value and uniqueness of the company in the pharmacy market, what’s next on the horizon, and the upcoming event.

529

529

Drug Topics

DECEMBER 17, 2024

Triptans are used to treat acute migraine and cluster headaches.

247

247

Drug Topics

JULY 2, 2024

Three posters presented at the American Diabetes Association 84th Scientific Sessions examined GLP-1 use and cardiovascular disease risk in several different patient populations.

281

281

Drug Topics

MARCH 13, 2024

Recent studies on daylight saving time’s association with increased health risks have heightened the debate on whether to observe the biannual event or switch to one universal time.

503

503

Drug Topics

FEBRUARY 6, 2024

A new study found that over a quarter of participants with type 1 daiebets exhibited clinically relevant levels of posttraumatic stress symptoms related to a diabetes event that they experienced.

503

503

Drug Topics

MARCH 10, 2025

The event will focus on clinical practice expansion for community pharmacies and how to make them a revenue-generating health care destination.

Community Pharmacies 389

Community Pharmacies 389

Drug Topics

DECEMBER 7, 2022

Cost savings were not associated with an increase in adverse drug events.

468

468

Drug Topics

FEBRUARY 19, 2024

After myocardial infarction, all-cause mortality was the most frequent event, followed by heart failure, renal failure, and atrial fibrillation.

468

468

Pharmacy Times

MARCH 24, 2025

National Adverse Drug Event Awareness Day was established to promote awareness, drive policy changes, and encourage health care professionals and patients to prioritize medication safety.

132

132

Drug Topics

AUGUST 28, 2023

A recent systematic review found no serious adverse events related to the use of cannabis for the management of cancer-related symptoms in children.

469

469

Drug Topics

NOVEMBER 4, 2022

Medical experts discuss potential long-term adverse effects associated with COVID-19.

247

247

Drug Topics

SEPTEMBER 20, 2022

Vaccination discussion continues with a focus on navigating patient concerns and potential adverse effects to vaccine administration.

Vaccines 247

Vaccines 247

Drug Topics

FEBRUARY 13, 2024

Many patients with the condition continue to experience severe hypoglycemic events even with the use of continuous glucose monitors and other disease management tools.

423

423

Fierce Healthcare

MAY 8, 2024

Ascension disclosed Wednesday that it has detected “unusual activity” on some of its technology networks that it believes “is due to a cybersecurity event.” | The Catholic health giant said it detected "unusual activity" Wednesday and "immediately" activated remediation processes, including hiring a third-party cybersecurity firm. (..)

142

142

Drug Topics

MARCH 6, 2024

Positive results from the FLOW trial demonstrate the potential for Ozempic to become the first GLP-1 treatment option for people living with type 2 diabetes and chronic kidney disease.

247

247

Drug Topics

APRIL 1, 2024

The can’t-miss event on April 13 features speakers and CE sessions focused on elevating patient-centric care.

360

360

Pharmacy Times

DECEMBER 24, 2024

Factors associated with intravenous immunoglobulin (IVIG)-related adverse events include older age, dehydration, and administration of multiple IVIG infusions.

139

139

Drug Topics

SEPTEMBER 5, 2023

The majority of persistent irAEs were hypothyroid, adrenal insufficiency, arthritis, dermatitis or pruritis, and hypophysitis.

Immunization 247

Immunization 247

Fierce Healthcare

DECEMBER 27, 2023

A hospital’s acquisition by a private equity firm is linked to a rise in adverse events despite the pool of lower risk patients they tend to admit, according to a Medicare Part A claims analysis pu | Hospital-acquired adverse events among Medicare beneficiaries were 25% higher within the three years after a private equity acquisition compared to control (..)

Hospitals 136

Hospitals 136

Drug Topics

JULY 8, 2024

When used together, sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were able to lower the risk of major adverse cardiovascular events and kidney disease by 11% and 33%, respectively.

343

343

Drug Topics

MARCH 3, 2025

Patients in the study could tolerate food allergens more, with fewer adverse events or reactions, compared with multi-allergen oral immunotherapy.

281

281

Pharmacy Times

MARCH 21, 2025

Non-high-density lipoprotein cholesterol was found to be more effective at predicting cardiovascular events such as stroke, myocardial outcomes, heart failure, and others compared with low-density lipoprotein cholesterol.

111

111

pharmaphorum

OCTOBER 8, 2024

Collaboration is essential for the future of healthcare, and events play a pivotal role in fostering it. Learn how collaboration can drive innovation in healthcare through impactful events.

122

122

Pharmacy Times

NOVEMBER 12, 2024

High COVID-19 hospital caseload strain led to increases in inpatient adverse events among patients both with and without SARS-CoV-2 infection.

Hospitals 132

Hospitals 132

Drug Topics

JULY 16, 2024

Look back at some of the amazing insights during McKesson ideaShare, the premier event for community pharmacists.

281

281

Drug Topics

SEPTEMBER 30, 2024

The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.

281

281

Drug Topics

JULY 18, 2024

Patients using isCGM had reduced glucose variability, time in low glucose range, time in very low glucose range, and less events related to low glucose levels.

281

281

Pharmacy Times

MARCH 18, 2025

Reducing the dose of ibrutinib following adverse events improved tolerability without compromising clinical efficacy in chronic lymphocytic leukemia (CLL).

95

95

Drug Topics

JUNE 3, 2024

Research presented at ENDO 2024 found that environmental stress increased the likelihood of earlier alcohol, nicotine and cannabis use in females and traumatic events increased the likelihood in males.

281

281

Fierce Pharma

AUGUST 13, 2024

When the FDA approved Amgen’s Imdelltra in May, the T-cell engager was hailed as a breakthrough for the treatment of small cell lung cancer (SCLC) and as the first DLL3-targeting therapy of potenti | In granting an accelerated approval to Amgen's first-in-class DLL3 bispecific Imdelltra, the FDA had to work through a “large number” of missing (..)

FDA 117

FDA 117